Meirong Zhou

Shikonin and chitosan-silver nanoparticles synergize against triple-negative breast cancer through RIPK3-triggered necroptotic immunogenic cell death

Jiahao Liang, Xiangge Tian, Meirong Zhou et al. · Biomaterials · 2024 · 51 citations

Nanoparticles, Nanomedicine, Engineering +13

Long non‑coding RNA SNHG1 promotes breast cancer progression by regulation of LMO4

Xiang Xiong, Yeqian Feng, Lun Li et al. · Oncology Reports · 2020 · 40 citations · Full text

Breast Oncology, Genetics, Breast Cancer Tissues +22

METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2—breast cancer

Dengjie Ouyang, Tao Hong, Mengdie Fu et al. · Breast Cancer Research · 2023 · 20 citations · Full text

Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study

Meirong Zhou, Shouman Wang, Nengbin Wan et al. · Annals of Translational Medicine · 2022 · 19 citations · Full text

Association between diabetes status and breast cancer in US adults: findings from the US National Health and Nutrition Examination Survey

Xingyu Sun, Qiangsong Zhang, Kaisaierjiang Kadier et al. · Frontiers in Endocrinology · 2023 · 17 citations · Full text